Home Cart 0 Sign in  
X

[ CAS No. 446-34-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 446-34-4
Chemical Structure| 446-34-4
Chemical Structure| 446-34-4
Structure of 446-34-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 446-34-4 ]

Related Doc. of [ 446-34-4 ]

Alternatived Products of [ 446-34-4 ]

Product Details of [ 446-34-4 ]

CAS No. :446-34-4 MDL No. :MFCD00007053
Formula : C7H6FNO2 Boiling Point : -
Linear Structure Formula :- InChI Key :WZMOWQCNPFDWPA-UHFFFAOYSA-N
M.W : 155.13 Pubchem ID :67966
Synonyms :

Calculated chemistry of [ 446-34-4 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.14
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 40.19
TPSA : 45.82 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.68 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.48
Log Po/w (XLOGP3) : 2.21
Log Po/w (WLOGP) : 2.46
Log Po/w (MLOGP) : 1.63
Log Po/w (SILICOS-IT) : 0.54
Consensus Log Po/w : 1.66

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.53
Solubility : 0.456 mg/ml ; 0.00294 mol/l
Class : Soluble
Log S (Ali) : -2.81
Solubility : 0.242 mg/ml ; 0.00156 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.43
Solubility : 0.576 mg/ml ; 0.00372 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.56

Safety of [ 446-34-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302+H312+H332-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 446-34-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 446-34-4 ]
  • Downstream synthetic route of [ 446-34-4 ]

[ 446-34-4 ] Synthesis Path-Upstream   1~19

  • 1
  • [ 446-34-4 ]
  • [ 10394-40-8 ]
Reference: [1] Patent: WO2015/175845, 2015, A1,
  • 2
  • [ 446-34-4 ]
  • [ 131019-87-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 21, p. 4790 - 4793
[2] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 6, p. 1455 - 1459
[3] Tetrahedron Letters, 2002, vol. 43, # 41, p. 7303 - 7306
  • 3
  • [ 352-70-5 ]
  • [ 446-33-3 ]
  • [ 446-34-4 ]
Reference: [1] Journal of Organic Chemistry, 1998, vol. 63, # 23, p. 8448 - 8454
  • 4
  • [ 591-09-3 ]
  • [ 352-70-5 ]
  • [ 446-33-3 ]
  • [ 446-34-4 ]
Reference: [1] Bl. Soc. Sci. Lett. Lodz, 1952, vol. 3, # 15, p. 4[2] Chem.Abstr., 1955, p. 203
  • 5
  • [ 578-46-1 ]
  • [ 446-34-4 ]
Reference: [1] Journal of the American Chemical Society, 2005, vol. 127, # 8, p. 2376 - 2377
  • 6
  • [ 352-70-5 ]
  • [ 446-33-3 ]
  • [ 446-34-4 ]
Reference: [1] Journal of Organic Chemistry, 1998, vol. 63, # 23, p. 8448 - 8454
  • 7
  • [ 352-70-5 ]
  • [ 446-34-4 ]
Reference: [1] Chemische Berichte, 1929, vol. 62, p. 1804
[2] Journal of Organic Chemistry, 1961, vol. 26, p. 3351 - 3356
  • 8
  • [ 591-09-3 ]
  • [ 352-70-5 ]
  • [ 446-33-3 ]
  • [ 446-34-4 ]
Reference: [1] Bl. Soc. Sci. Lett. Lodz, 1952, vol. 3, # 15, p. 4[2] Chem.Abstr., 1955, p. 203
  • 9
  • [ 446-34-4 ]
  • [ 452-81-3 ]
Reference: [1] Journal of the American Chemical Society, 1959, vol. 81, p. 94,95, 97
  • 10
  • [ 446-34-4 ]
  • [ 825-98-9 ]
Reference: [1] Journal of Organic Chemistry, 1961, vol. 26, p. 3351 - 3356
  • 11
  • [ 446-34-4 ]
  • [ 452-80-2 ]
Reference: [1] Journal of the American Chemical Society, 1959, vol. 81, p. 94,95, 97
[2] Acta Chemica Scandinavica (1947-1973), 1955, vol. 9, p. 1079,1083
[3] Bl.Soc.Sci.Lett.Lodz, 1952, vol. <3>3, # 15, p. 6
[4] Journal of Organic Chemistry, 1961, vol. 26, p. 3351 - 3356
[5] Journal of Medicinal Chemistry, 2000, vol. 43, # 26, p. 5017 - 5029
  • 12
  • [ 51632-16-7 ]
  • [ 446-34-4 ]
  • [ 452-80-2 ]
Reference: [1] Patent: US4243819, 1981, A,
  • 13
  • [ 446-34-4 ]
  • [ 108-24-7 ]
  • [ 326-67-0 ]
Reference: [1] Journal of Organic Chemistry, 1961, vol. 26, p. 3351 - 3356
  • 14
  • [ 446-34-4 ]
  • [ 5081-36-7 ]
Reference: [1] Journal of the American Chemical Society, 1944, vol. 66, p. 1631
  • 15
  • [ 446-34-4 ]
  • [ 455-87-8 ]
Reference: [1] Journal of the American Chemical Society, 1944, vol. 66, p. 1631
[2] Journal of Organic Chemistry, 1961, vol. 26, p. 3351 - 3356
  • 16
  • [ 446-34-4 ]
  • [ 403-21-4 ]
YieldReaction ConditionsOperation in experiment
83% With potassium dichromate; sulfuric acid In acetic acid at 120℃; for 2 h; 2-Fluoro-4-methyl-l-nitro-benzene (1.0 g, 12.9 mmol) was added portion- wise to a suspension of potassium dichromate (5.04 g, 17.16 mmol) in glacial acetic acid (8 mL) follow by concentrated sulfuric acid (3.6 mL). The reaction mixture was heated to 1200C for 2 h and then allowed to cool to ambient temperature. The reaction was quenched with crushed ice and extracted with ethyl acetate. The organic layer was washed with brine, dried over anhydrous sodium sulfate and concentrated in vacuo to afford 3-fluoro-4-nitro-benzoic acid (1.9 g, 83percent) as a white solid.
82.9% With potassium permanganate In ethyl acetate Reference Example 39
An aqueous solution (50 mL) containing 3-fluoro-4-nitrotoluene (2.0 g, 12.9 mmol) and potassium permanganate (4.07 g, 25.8 mmol) was heated under reflux for 15 hours.
The reaction solution was cooled and then aqueous phase was washed with ethyl acetate.
The aqueous phase was acidified with 4 N aqueous hydrochloric acid solution, and the precipitated crystals were collected by filtration.
The filtrate was extracted with ethyl acetate five times.
The crystals collected by filtration were dissolved in ethyl acetate, and combined with the ethyl acetate extraction solution.
The ethyl acetate layer combined was washed with water and then with saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure, to obtain 3-fluoro-4-nitrobenzoic acid (1.07 g, 82.9percent) as pale yellow crystals.
1H-NMR(CDCl3)δ:8.01-8.06(1H,m),8.12-8.18 (1H,m) ppm
FABMS:186(M+1)
68% With sodium dichromate; sulfuric acid In water at 0 - 90℃; for 4.3 h; (a)
Synthesis of 3-fluoro-4-nitrobenzoic acid
Sodium dichromate (6.50 g, 21.8 mmol) was added to a suspension of 3-fluoro-4-nitrotoluene (2.50 g, 16.0 mmol) in water (19 ml) under ice-cooling, and concentrated sulfuric acid (14.7 ml) was added dropwise thereto at 6°C over a period of 2 hours.
After completion of the dropwise addition, an ice-water bath was removed and the mixture obtained was allowed to stand for 20 minutes until its temperature became room temperature.
Thereafter, the mixture was heated and then stirred at 90°C for 2 hours.
After completion of the reaction, water (50 ml) was poured into the reaction mixture under ice-cooling, and the resulting mixture was stirred at room temperature for a while.
This mixture was extracted twice with ethyl acetate and then the organic layer was washed three times with a 2N-aqueous sodium hydroxide solution.
The aqueous layer was acidified with 6N-hydrochloric acid and extracted with ethyl acetate.
The organic layer was washed with a saturated aqueous sodium chloride solution, dried over magnesium sulfate and then filtered.
The filtrate was concentrated and the crude product thus obtained was purified by a silica gel column chromatography (eluent: chloroform/methanol = 8/2) to obtain 3-fluoro-4-nitrobenzoic acid (2.00 g, 68percent).
58% With potassium permanganate In water for 6 h; Heating / reflux Stage 1:
3-fluoro-4-nitrobenzoic acid
A mixture of 3-fluoro-4-nitrotoluene (10 g, 1 eq) and potassium permanganate (25.5 g, 2.5 eq) in water (1 L) is heated under reflux for 6 hours then cooled down to ambient temperature.
The mixture is filtered on celite and the aqueous phase is washed twice with diethyl ether (2*300 ml).
The aqueous phase is acidified, at 0° C., with a solution of concentrated hydrochloric acid then concentrated under reduced pressure at 40° C. to a volume of approximately 300 ml.
The precipitate formed is filtered then washed with petroleum ether and dried in order to produce the expected compound in the form of a white solid (6.9 g; 58percent yield).
NMR (1H, 400 MHz, DMSO-d6): δ 7.93 (m, 2H), 8.25 (m, 1H), 13.95 (m, 1H).
58%
Stage #1: With potassium permanganate In water for 6 h; Reflux
Stage #2: at 0℃;
EXAMPLE A1; N,N-bis(3-methylbutyl)-11-oxo-5-(3-piperidin-1-ylpropyl)-5,11-dihydrothieno[3',2':4,5]pyrimido[1,2-a]benzimidazole-7-carboxamide hydrochloride; Stage 1: 3-fluoro-4-nitrobenzoic acid; A mixture of 3-fluoro-4-nitrotoluene (10 g, 1 eq) and potassium permanganate (25.5 g, 2.5 eq) in water (1 L) is heated under reflux for 6 hours then cooled down to ambient temperature. The mixture is filtered on celite and the aqueous phase is washed twice with diethyl ether (2.x.300 ml). The aqueous phase is acidified, at 0° C., with a solution of concentrated hydrochloric acid then concentrated under reduced pressure at 40° C. to a volume of approximately 300 ml. The precipitate formed is filtered then washed with petroleum ether and dried in order to produce the expected compound in the form of a white solid (6.9 g; 58percent yield).NMR (1H, 400 MHz, DMSO-d6): δ 7.93 (m, 2H), 8.25 (m, 1H), 13.95 (m, 1H).
58% With potassium permanganate In water for 6 h; Heating / reflux Stage 1:
3-fluoro-4-nitrobenzoic acid
A mixture of 3-fluoro-4-nitrotoluene (10 g, 1 eq) and potassium permanganate (25.5 g, 2.5 eq) in water (1 l) is heated to reflux for 6 hours then cooled down to ambient temperature.
The mixture is filtered on celite and the aqueous phase is washed twice with diethyl ether (2*300 ml).
The aqueous phase is acidified with an aqueous solution of concentrated hydrochloric acid (12N) then concentrated under reduced pressure at 40° C. to a volume of approximately 300 ml.
The precipitate formed is filtered then washed with petroleum ether and dried in order to produce the expected compound in the form of a white solid (6.9 g; 58percent yield).
NMR 1H (400 MHz, DMSO-d6): δ7.93 (m, 2H), 8.25 (m, 1H), 13.95 (m, 1H).
24% With sodium dichromate; sulfuric acid In water at 90 - 100℃; for 1 - 2 h; Concentrated H2SO4 (190 mL) was added dropwise to a cooled solution of 3-fluoro-4- nitrotoluene (161.2 mmol, 25 g) and sodium dichromate dihydrate (225.6 mmol, 67.2 g) in water (200 mL). The addition was carried out while maintaining the temperature of the reaction mixture below 10 [C.] Once the addition was complete, the solution was refluxed at 100 [C] for approximately 2 h. The reaction mixture was cooled to room temperature, diluted with H20 (200 mL) and the product extracted with ethyl acetate. The organic extracts were combined and extracted with a solution of 2N sodium hydroxide. The basic phase was acidified with concentrated [HC1] to afford (65.9 mmol, 12.2 g) as an off-white solid precipitate (yield: 40.8percent). The precipitate was further purified by recrystallization from an ethanol/water mixture to afford 3-fluoro-4- nitrobenzoic acid as white crystals.To a solution [OF 3-FLUORO-4-NITROTOLUENE] (22.45 g, 144.7 mmol) and sodium dichromate dihydrate (60.38 g, 202.6 mmol) in water at [0 C] was added concentrated sulfuric acid (140 mL) dropwise over 3 h. When the addition was complete, the solution was allowed to warm to room temperature over [1] h, and then brought to 90 C for 1 h. The mixture was allowed to cool to room temperature, diluted with 300 mL water and extracted with ethyl acetate (3 x 250 mL). The combined organic extracts were concentrated down to 300 mL and extracted with [1] N NaOH (3 x 250 mL). The aqueous extracts were acidified with 6 N [HC1] and extracted with ethyl acetate (3 x 300 mL). The combined organic extracts were dried over [MGS04] and concentrated to give a gummy solid. Trituration with hexane gave the [3-FLUORO-4-NITROBENZOIC] acid as a solid that was collected by filtration (6.51 g, 24percent).
68% With Na2Cr2O7; sulfuric acid In sodium hydroxide; water Example 8
Synthesis of 3-Fluoro-4-[3-Pentyl-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-yl)-Ureido]-Benzoic Acid
A solution of 3-fluoro-4-nitrotoluene (2 g, 12.82 mmole) in 13 mL water, containing 5.72 g of Na2Cr2O7, was treated dropwise with 14.2 mL of concentrated sulfuric acid, stirred at room temperature for one hour and then diluted with 20 mL of water.
The mixture was filtered and the recovered solid was gently heated in 50 mL 2percent sodium hydroxide solution.
The resulting solution was cooled and filtered and the filtrate was acidified with concentrated HCl.
The aqueous phase was extracted with two 100 mL portions of ethyl acetate, the combined extracts were washed with 100 mL of aqueous saturated sodium chloride solution, dried over MgSO4, filtered and concentrated in vacuo to give 1.6 g (68percent) of 3-fluoro-4-nitrobenzoic acid as a yellow solid.

Reference: [1] Patent: WO2009/130481, 2009, A1, . Location in patent: Page/Page column 145
[2] Journal of Medicinal Chemistry, 2005, vol. 48, # 6, p. 1729 - 1744
[3] Patent: EP1820799, 2007, A1,
[4] Patent: WO2006/51851, 2006, A1, . Location in patent: Page/Page column 60-61
[5] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 5, p. 1386 - 1391
[6] Patent: EP1500643, 2005, A1, . Location in patent: Page 39
[7] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 4, p. 1043 - 1046
[8] European Journal of Medicinal Chemistry, 1999, vol. 34, # 3, p. 225 - 234
[9] Patent: US2005/65179, 2005, A1, . Location in patent: Page/Page column 9
[10] Patent: US2009/209531, 2009, A1, . Location in patent: Page/Page column 5
[11] Patent: US2006/281784, 2006, A1, . Location in patent: Page/Page column 8
[12] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 13, p. 4345 - 4359
[13] Patent: US4483986, 1984, A,
[14] Patent: WO2004/14905, 2004, A1, . Location in patent: Page 157; 157
[15] Journal of the American Chemical Society, 1944, vol. 66, p. 1631
[16] Journal of Medicinal Chemistry, 1983, vol. 26, # 8, p. 1193 - 1196
[17] Patent: US2003/158226, 2003, A1,
[18] Patent: US5624957, 1997, A,
  • 17
  • [ 51632-16-7 ]
  • [ 446-34-4 ]
  • [ 69409-98-9 ]
Reference: [1] Patent: US4243819, 1981, A,
  • 18
  • [ 446-34-4 ]
  • [ 160538-51-2 ]
YieldReaction ConditionsOperation in experiment
29.2%
Stage #1: at 5 - 10℃; for 3 h;
Stage #2: for 0.25 h;
Stage #3: for 0.25 h; Heating / reflux
Preparation of Compound 5, Sodium Salt; [0057] Sulfuric acid (14.5 mL) was slowly added to a solution of 3-fluoro-4-nitrotoluene (10.0 g, 64 mmol) in acetic acid (75 mL) at 5° C. Cromium trioxide (17.92 g, 180 mmol) was added slowly over 1 hour. The reaction was kept below 10° C. for an additional 2 hours and then poured into ice water (700 mL) and the resulting yellow solids filtered off. The solids were stirred in 2percent NaHCO3 for 15 minutes, filtered, dried in vacuo, then heated to reflux for 15 minutes in a solution of: water (60 mL), concentrated HCl (40 mL), and ethanol (11 mL). The yellow solids were isolated by filtration, 3.16 g 4-nitro-2-fluorobenzaldehyde (29.2percent yield).
Reference: [1] Journal of Organic Chemistry, 2001, vol. 66, # 21, p. 7223 - 7226
[2] Patent: US2003/216589, 2003, A1, . Location in patent: Page/Page column 6
[3] Tetrahedron Letters, 1994, vol. 35, # 45, p. 8465 - 8468
  • 19
  • [ 446-34-4 ]
  • [ 185629-31-6 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 4, p. 1043 - 1046
Same Skeleton Products
Historical Records